As was depicted in Figure 1A, SOX13 was expressed remarkably higher in cholangiocarcinoma (CHOL), breast invasive carcinoma (BRCA), esophageal carcinoma (ESCA), etc. compared to normal tissues. Here, SOX13 is linked to carcinoma of esophagus.